Title: Can the Simplified Magnetic Resonance Index of Activity be Used to Evaluate
the Degree of Activity in Crohn's Disease?
Version: 1 Date: 20 May 2021
Reviewer's report:
This is a well-designed and interesting study. However, I've detected a few issues:
In Table 1, please clarify disease location (L) according to Montreal classification.
In Table 2, you are analyzing disease activity. How could you explain 106 terminal ileum
segments while you are analyzing 93 patients? The same with all other segments.
Please indicate the normal range of FC.
Table 3, please indicate what biomarkers values you are writing means (range) or median
(interquartile range)?
The discussion could be more "deeper. "
What are the advantages and differences of your article from this one?
Roseira J, Ventosa AR, de Sousa HT, Brito J. The new simplified MARIA score applies
beyond clinical trials: A suitable clinical practice tool for Crohn's disease that parallels
a simple endoscopic index and fecal calprotectin. United European Gastroenterol J. 2020
Dec;8(10):1208-1216. doi: 10.1177/2050640620943089. Epub 2020 Jul 14. PMID: 32664824;
PMCID: PMC7724527.
Title: Can the Simplified Magnetic Resonance Index of Activity be Used to Evaluate
the Degree of Activity in Crohn's Disease?
Version: 1 Date: 20 May 2021
Reviewer's report:
This is a well-designed and interesting study. However, I've detected a few issues:
In Table 1, please clarify disease location (L) according to Montreal classification.
In Table 2, you are analyzing disease activity. How could you explain 106 terminal ileum
segments while you are analyzing 93 patients? The same with all other segments.
Please indicate the normal range of FC.
Table 3, please indicate what biomarkers values you are writing means (range) or median
(interquartile range)?
The discussion could be more "deeper. "
What are the advantages and differences of your article from this one?
Roseira J, Ventosa AR, de Sousa HT, Brito J. The new simplified MARIA score applies
beyond clinical trials: A suitable clinical practice tool for Crohn's disease that parallels
a simple endoscopic index and fecal calprotectin. United European Gastroenterol J. 2020
Dec;8(10):1208-1216. doi: 10.1177/2050640620943089. Epub 2020 Jul 14. PMID: 32664824;
PMCID: PMC7724527.
Please review this paper.
user
Title: Can the Simplified Magnetic Resonance Index of Activity be Used to Evaluate
the Degree of Activity in Crohn's Disease?
Version: 1 Date: 20 May 2021
Reviewer's report:
This is a well-designed and interesting study. However, I've detected a few issues:
In Table 1, please clarify disease location (L) according to Montreal classification.
In Table 2, you are analyzing disease activity. How could you explain 106 terminal ileum
segments while you are analyzing 93 patients? The same with all other segments.
Please indicate the normal range of FC.
Table 3, please indicate what biomarkers values you are writing means (range) or median
(interquartile range)?
The discussion could be more "deeper. "
What are the advantages and differences of your article from this one?
Roseira J, Ventosa AR, de Sousa HT, Brito J. The new simplified MARIA score applies
beyond clinical trials: A suitable clinical practice tool for Crohn's disease that parallels
a simple endoscopic index and fecal calprotectin. United European Gastroenterol J. 2020
Dec;8(10):1208-1216. doi: 10.1177/2050640620943089. Epub 2020 Jul 14. PMID: 32664824;
PMCID: PMC7724527.
assistant